Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$601M |
| 2 |
Parker-Hannifin
PH
|
+$576M |
| 3 |
JPMorgan Chase
JPM
|
+$575M |
| 4 |
Goldman Sachs
GS
|
+$452M |
| 5 |
FedEx
FDX
|
+$371M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$733M |
| 2 |
American Tower
AMT
|
+$684M |
| 3 |
Nike
NKE
|
+$601M |
| 4 |
AGN
Allergan plc
AGN
|
+$561M |
| 5 |
McDonald's
MCD
|
+$536M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 17.46% |
| 3 | Healthcare | 13.37% |
| 4 | Communication Services | 12.12% |
| 5 | Financials | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAK
526
Northern Dynasty Minerals
NAK
$857M
| $3.65M | ﹤0.01% |
1,763,422
-17,542
| -1% | -$20.4K |
|
527
Citizens Financial Group
CFG
$30.1B
| $3.6M | ﹤0.01% |
101,183
-30,064
| -23% | -$911K |
|
528
APA Corp
APA
$12.3B
| $3.58M | ﹤0.01% |
56,436
+52,123
| +1,209% | +$3.28M |
|
529
Stryker
SYK
$129B
| $3.51M | ﹤0.01% |
29,275
+18,635
| +175% | +$2.14M |
|
|
XL
530
DELISTED
XL Group Ltd.
XL
| $3.48M | ﹤0.01% |
+93,373
| New | +$3.35M |
|
531
Keurig Dr Pepper
KDP
$41B
| $3.38M | ﹤0.01% |
+37,333
| New | +$3.27M |
|
532
Tempest Therapeutics
TPST
$14.9M
| $3.34M | ﹤0.01% |
747
-266
| -26% | -$3.31M |
|
533
State Street SPDR S&P Metals & Mining ETF
XME
$3.96B
| $3.24M | ﹤0.01% |
106,491
-572
| -0.5% | -$16.5K |
|
|
RARX
534
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $3.08M | ﹤0.01% |
+202,500
| New | +$2.75M |
|
535
McKesson
MCK
$99.5B
| $2.99M | ﹤0.01% |
+21,314
| New | +$3.14M |
|
536
CALL
Bausch Health
BHC
$1.67B
| $2.9M | ﹤0.01% |
200,000
| – | – |
|
537
Elevance Health
ELV
$82.1B
| $2.65M | ﹤0.01% |
18,447
-7,641
| -29% | -$1.02M |
|
538
Coca-Cola
KO
$362B
| $2.6M | ﹤0.01% |
62,838
+55,674
| +777% | +$2.32M |
|
539
Warner Bros
WBD
$63.4B
| $2.51M | ﹤0.01% |
91,683
-37,090
| -29% | -$1.01M |
|
540
Webster Financial
WBS
$12.5B
| $2.51M | ﹤0.01% |
46,239
-11,588
| -20% | -$532K |
|
541
Prosperity Bancshares
PB
$8.69B
| $2.49M | ﹤0.01% |
34,673
-210,218
| -86% | -$13.1M |
|
542
Stanley Black & Decker
SWK
$14.6B
| $2.46M | ﹤0.01% |
21,436
+1,971
| +10% | +$235K |
|
543
Whirlpool
WHR
$2.44B
| $2.44M | ﹤0.01% |
13,451
+10,960
| +440% | +$1.81M |
|
|
VSM
544
DELISTED
Versum Materials, Inc.
VSM
| $2.34M | ﹤0.01% |
+83,471
| New | +$2.08M |
|
545
Trane Technologies
TT
$107B
| $2.3M | ﹤0.01% |
30,668
-17,863
| -37% | -$1.29M |
|
546
iShares MSCI India ETF
INDA
$6.77B
| $2.27M | ﹤0.01% |
+84,650
| New | +$2.35M |
|
|
LHO
547
DELISTED
LaSalle Hotel Properties
LHO
| $2.23M | ﹤0.01% |
73,343
+26,603
| +57% | +$715K |
|
|
TEN
548
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.22M | ﹤0.01% |
35,479
-3,296
| -9% | -$193K |
|
549
PUT
Vertex Pharmaceuticals
VRTX
$122B
| $2.19M | ﹤0.01% |
+29,700
| New | +$2.42M |
|
550
Glacier Bancorp
GBCI
$6.38B
| $2.09M | ﹤0.01% |
57,628
-9,542
| -14% | -$307K |
|
Similar funds
Jennison Associates's Q4 2016 Portfolio in Review
As of Q4 2016, Jennison Associates held 857 positions worth $89.6B, down 3.4% from $92.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.76B in Q4 2016, closing 52 positions and reducing 313 holdings. Its most notable exit was lululemon athletica, an estimated $342M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Parker-Hannifin worth $606M.
- Jennison Associates's largest Q4 2016 buy was Parker-Hannifin: 4,330,276 shares worth $606M.
- Jennison Associates added most to Charter Communications in Q4 2016, an estimated $601M increase.
- Jennison Associates's biggest Q4 2016 reduction was Biogen, cutting an estimated $733M.
- Jennison Associates fully exited lululemon athletica in Q4 2016, selling an estimated $342M.
- Jennison Associates's ten largest holdings make up 25% of its $89.6B portfolio in Q4 2016.
- Jennison Associates opened 208 new positions and closed 52 in Q4 2016.
- Jennison Associates's portfolio value fell 3.4% quarter-over-quarter to $89.6B.
Based on Jennison Associates's 13F filing for Q4 2016, filed 6 Feb 2017.